KR880001078B1 - 1-치환 아릴-1, 4-디히드로-4-옥소나프티리딘 유도체의 제조방법 - Google Patents

1-치환 아릴-1, 4-디히드로-4-옥소나프티리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR880001078B1
KR880001078B1 KR1019860000388A KR860000388A KR880001078B1 KR 880001078 B1 KR880001078 B1 KR 880001078B1 KR 1019860000388 A KR1019860000388 A KR 1019860000388A KR 860000388 A KR860000388 A KR 860000388A KR 880001078 B1 KR880001078 B1 KR 880001078B1
Authority
KR
South Korea
Prior art keywords
group
formula
compound
salt
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019860000388A
Other languages
English (en)
Korean (ko)
Other versions
KR860005817A (ko
Inventor
요조 도도
데쭈오 야마후지
가쭈유끼 나구모
이사오 기따야마
히데요시 나가끼
미까꼬 미야지마
요시노리 고니시
히로까주 나리따
순따로 다까노
이사무 사이까와
Original Assignee
도야마 가가꾸 가부시끼가이샤
나까노 다다오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60009191A external-priority patent/JPH0629247B2/ja
Priority claimed from JP60028397A external-priority patent/JPH0629246B2/ja
Priority claimed from JP60043644A external-priority patent/JPH0665670B2/ja
Priority claimed from JP60069061A external-priority patent/JPH0665671B2/ja
Priority claimed from JP60097065A external-priority patent/JPH0662619B2/ja
Priority claimed from JP60129323A external-priority patent/JPH0665672B2/ja
Application filed by 도야마 가가꾸 가부시끼가이샤, 나까노 다다오 filed Critical 도야마 가가꾸 가부시끼가이샤
Publication of KR860005817A publication Critical patent/KR860005817A/ko
Application granted granted Critical
Publication of KR880001078B1 publication Critical patent/KR880001078B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019860000388A 1985-01-23 1986-01-22 1-치환 아릴-1, 4-디히드로-4-옥소나프티리딘 유도체의 제조방법 Expired KR880001078B1 (ko)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP60009191A JPH0629247B2 (ja) 1985-01-23 1985-01-23 ５−フルオロニコチン酸誘導体およびその塩
JP9191 1985-01-23
JP60028397A JPH0629246B2 (ja) 1985-02-18 1985-02-18 ２−（５−フルオロニコチノイル）酢酸誘導体およびその塩
JP60043644A JPH0665670B2 (ja) 1985-03-07 1985-03-07 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP43644 1985-03-07
JP60069061A JPH0665671B2 (ja) 1985-04-03 1985-04-03 １−置換アリ−ル−１，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP69061 1985-04-03
JP97065 1985-05-08
JP60097065A JPH0662619B2 (ja) 1985-05-08 1985-05-08 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP129323 1985-06-14
JP60129323A JPH0665672B2 (ja) 1985-06-14 1985-06-14 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP28397 1997-01-06

Publications (2)

Publication Number Publication Date
KR860005817A KR860005817A (ko) 1986-08-13
KR880001078B1 true KR880001078B1 (ko) 1988-06-22

Family

ID=27548185

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860000388A Expired KR880001078B1 (ko) 1985-01-23 1986-01-22 1-치환 아릴-1, 4-디히드로-4-옥소나프티리딘 유도체의 제조방법

Country Status (20)

Country Link
US (1) US4704459A (enExample)
KR (1) KR880001078B1 (enExample)
AT (1) AT392789B (enExample)
BE (1) BE904086A (enExample)
CA (2) CA1340706C (enExample)
CH (2) CH671957A5 (enExample)
DE (2) DE3637679C1 (enExample)
DK (3) DK169570B1 (enExample)
FI (2) FI83313C (enExample)
FR (1) FR2576305B1 (enExample)
GB (2) GB2170804B (enExample)
IL (1) IL77688A (enExample)
IT (1) IT1190193B (enExample)
LU (1) LU86264A1 (enExample)
NL (1) NL192986C (enExample)
NO (1) NO163227C (enExample)
NZ (1) NZ214901A (enExample)
PH (2) PH23202A (enExample)
PT (1) PT81889B (enExample)
SE (3) SE462164B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US4916229A (en) * 1987-07-28 1990-04-10 Warner-Lambert Company Pyridine carboxylic acid derivates
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
DE3729852A1 (de) * 1987-09-05 1989-03-23 Basf Ag Verfahren zur herstellung von 1-alkylimidazol-5-carbonsaeuren sowie deren estern, amiden und nitrilen
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) * 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
WO1992012155A1 (en) * 1991-01-14 1992-07-23 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
CA2168764C (en) * 1993-08-13 2000-01-18 Sung June Yoon Novel quinolone carboxylic acid derivatives
EP0788801A1 (en) * 1994-07-20 1997-08-13 Toyama Chemical Co., Ltd. Sustained-release oral ointment
US6313299B1 (en) 1997-06-26 2001-11-06 Dong Wha Pharmaceutical Industrial Co., Ltd. Quinolone carboxylic acid derivatives
WO2000032196A2 (en) 1998-12-04 2000-06-08 Influx, Inc. Inhibitors of multidrug transporters
CN102584799A (zh) 1999-09-16 2012-07-18 田边三菱制药株式会社 含氮的6-员芳香环化合物
US20080027037A1 (en) * 2000-04-28 2008-01-31 Tanabe Seiyaku Co., Ltd. Cyclic compounds
CN1657523A (zh) * 2000-04-28 2005-08-24 田边制药株式会社 环状化合物
US7273868B2 (en) * 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
NZ527741A (en) * 2001-02-26 2005-02-25 Tanabe Seiyaku Co Pyridopyrimidine or naphthyridine derivative
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
BRPI0416692A (pt) * 2003-11-19 2007-01-30 Array Biopharma Inc inibidores heterocìclicos de mek e métodos de emprego destes
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
NZ563707A (en) * 2005-05-18 2011-01-28 Array Biopharma Inc Heterocyclic inhibitors of MEK and methods of use thereof
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2007123939A2 (en) 2006-04-19 2007-11-01 Laboratoires Serono S.A. Novel arylamino n-heteraryls as mek inhibitors
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
MX2010008844A (es) * 2008-02-11 2010-09-07 Astrazeneca Ab Proceso para preparar derivados de piridona 226.
ES2806256T3 (es) 2010-10-12 2021-02-17 Bayer Ip Gmbh Productos masticables blandos no basados en almidón
UA118748C2 (uk) 2012-12-19 2019-03-11 Байєр Енімал Хелс Гмбх Таблетки, що мають покращене сприйняття та хорошу стабільність при зберіганні
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
CN113853196B (zh) 2019-05-24 2024-04-12 皮埃蒙特动物健康公司 长效可注射调配物和其用途
WO2021046305A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
GB1147336A (en) * 1965-06-14 1969-04-02 Lilly Industries Ltd Quinoline-3-carboxylic acid derivatives
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
GB1451911A (en) * 1972-08-14 1976-10-06 Dainippon Pharmaceutical Co 2-1-piperazino-5-oxopyrido-2,3,d-pyrimidine-6-carboxylic acids their preparation and pharmaceutical compositions thereof
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
DE3028520A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von chinolinen, naphtyridinen und anderen stickstoff-bi-heterocyclen
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Also Published As

Publication number Publication date
FR2576305A1 (fr) 1986-07-25
SE469984B (sv) 1993-10-18
GB2204040B (en) 1989-09-20
GB8811645D0 (en) 1988-06-22
CH667456A5 (de) 1988-10-14
DK169570B1 (da) 1994-12-05
SE8600274L (sv) 1986-09-10
DK285190D0 (da) 1990-11-30
GB2170804A (en) 1986-08-13
CH671957A5 (enExample) 1989-10-13
SE8902265D0 (sv) 1989-06-21
PH23202A (en) 1989-06-06
DK170532B1 (da) 1995-10-16
FI860250A7 (fi) 1986-07-24
DK285190A (da) 1990-11-30
BE904086A (fr) 1986-07-22
SE8600274D0 (sv) 1986-01-22
DE3601517A1 (de) 1986-08-21
DK170857B1 (da) 1996-02-12
DE3637679C1 (de) 1992-08-27
SE8902264L (sv) 1989-06-21
FI83313B (fi) 1991-03-15
SE8902264D0 (sv) 1989-06-21
NO860226L (no) 1986-07-24
PH22956A (en) 1989-02-03
LU86264A1 (fr) 1986-08-04
CA1340783C (en) 1999-10-12
NL192986B (nl) 1998-03-02
FI893075A7 (fi) 1989-06-22
NL8600138A (nl) 1986-08-18
ATA7286A (de) 1990-11-15
FI83313C (fi) 1991-06-25
FI87647C (fi) 1993-02-10
SE469983B (sv) 1993-10-18
PT81889B (pt) 1988-05-27
GB2204040A (en) 1988-11-02
SE462164B (sv) 1990-05-14
GB2170804B (en) 1989-09-20
DK285290A (da) 1990-11-30
CA1340706C (en) 1999-08-17
IL77688A (en) 1991-01-31
DK285290D0 (da) 1990-11-30
IT1190193B (it) 1988-02-16
DK32286A (da) 1986-07-24
NO163227C (no) 1990-04-25
IT8647562A0 (it) 1986-01-22
AT392789B (de) 1991-06-10
FR2576305B1 (fr) 1991-04-19
PT81889A (en) 1986-02-01
NO163227B (no) 1990-01-15
FI860250A0 (fi) 1986-01-20
KR860005817A (ko) 1986-08-13
DE3601517C2 (enExample) 1989-11-16
FI87647B (fi) 1992-10-30
GB8601045D0 (en) 1986-02-19
NZ214901A (en) 1989-01-27
NL192986C (nl) 1998-07-03
DK32286D0 (da) 1986-01-22
FI893075A0 (fi) 1989-06-22
SE8902265L (sv) 1989-06-21
US4704459A (en) 1987-11-03

Similar Documents

Publication Publication Date Title
KR880001078B1 (ko) 1-치환 아릴-1, 4-디히드로-4-옥소나프티리딘 유도체의 제조방법
JP4212354B2 (ja) アテローム性動脈硬化の治療のためのピリジノン誘導体
EP0228845B1 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
US4851535A (en) Nicotinic acid derivatives
CZ20024176A3 (cs) Způsob výroby pyrazolopyrimidinonů
FI85703B (fi) Foerfarande foer framstaellning av 1,4 -dihydro-4-oxonaftyridinderivat.
CA1340648C (en) Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and porcesses for producing the intermediates
CA1340793C (en) Process for producing 1-substituted aryl-1-4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and processes for producing the intermediates
CH669378A5 (en) 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn.
AT392791B (de) Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
DE3641633C2 (de) Neue 5-Fluornicotinsäurederivate, deren Salze und reaktive Derivate der Carboxylgruppe derselben
NO174888B (no) Nye 2-(5-fluornikotinoyl)-eddiksyrederivater
JPS61289088A (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JPS61189269A (ja) ２−（５−フルオロニコチノイル）酢酸誘導体およびその塩
JPH0665671B2 (ja) １−置換アリ−ル−１，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JPS61257985A (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JPH037260A (ja) 新規キノロン誘導体またはその塩及びこれを含有する抗菌剤
JPH0665670B2 (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JPH0629247B2 (ja) ５−フルオロニコチン酸誘導体およびその塩

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19860122

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19880216

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19880520

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19880905

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19881014

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19881014

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19910513

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19920429

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19930331

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19940426

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19950420

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19960529

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19970508

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19980522

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19990616

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20000614

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20010615

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20020604

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20030605

Start annual number: 16

End annual number: 16

PR1001 Payment of annual fee

Payment date: 20040609

Start annual number: 17

End annual number: 17

FPAY Annual fee payment

Payment date: 20050614

Year of fee payment: 18

PR1001 Payment of annual fee

Payment date: 20050614

Start annual number: 18

End annual number: 18

EXPY Expiration of term
PC1801 Expiration of term